Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Retained Earnings history
Currency unavailable · from the balance sheet
No Retained Earnings data reported for this period type.
Retained Earnings vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | -$148.58M USD | -29.8% | — | 37.8% |
| Mar 2026 | -$173.23M USD | -48.0% | — | 62.9% | |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | -$191.84M USD | -43.8% | — | 73.4% |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | -$255.09M USD | -72.6% | — | 51.3% |
| Mar 2026 | -$421.19M USD | -90.0% | — | 100.6% | |
| Mar 2026 | -$443.33M USD | -117.5% | — | 102.3% | |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | -$1.24B USD | -21.9% | — | 804.3% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -48.0% | — | 73.4% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.